| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15K | — | -63.5% |
| Cost of Revenue | $2K | — | -86.6% |
| Gross Profit | $13K | — | -52.2% |
| R&D Expense | $346K | — | -14.7% |
| SG&A Expense | $793K | — | -14.7% |
| Operating Income | -$2.1M | — | -5.4% |
| Interest Expense | -$34 | — | +96.9% |
| Pre-tax Income | -$2.1M | — | -5.5% |
| Net Income | -$2.1M | — | -5.5% |
| EPS (Basic) | -$0.11 | — | +26.7% |
| EPS (Diluted) | -$0.11 | — | +26.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.2M | +84.5% | +94.2% |
| Short-term Investments | $1.5M | -51.1% | +5.0% |
| Accounts Receivable | $43K | -47.3% | +197.0% |
| Inventory | $179K | +36.5% | +2.4% |
| Current Assets | $3.3M | -23.5% | +25.6% |
| Total Assets | $3.7M | -20.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.7M | — | -20.1% |
| Investing Cash Flow | $1.5M | — | +2.4% |
| Financing Cash Flow | $756K | — | — |
| +27.4% |
| Current Liabilities | $808K | -8.9% | +40.6% |
| Total Liabilities | $808K | -8.9% | +40.6% |
| Stockholders' Equity | $2.9M | -23.0% | +24.1% |